Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

261
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
05/22/2015 05/26/2015 05/27/2015 05/28/2015 05/29/2015 Date
388 390.1 394.1 386.5 379.3 Last
2009578 2670740 2206168 2610878 10197632 Volume
+0.91% +0.54% +1.03% -1.93% -1.86% Change
Financials ( DKK)
Sales 2015 108 747 M
EBIT 2015 47 722 M
Net income 2015 33 124 M
Finance 2015 10 166 M
Yield 2015 1,54%
Sales 2016 118 371 M
EBIT 2016 51 523 M
Net income 2016 39 508 M
Finance 2016 11 351 M
Yield 2016 1,86%
PER 2015 29,88
PER 2016 24,78
EV / Sales 2015 7,24x
EV / Sales 2016 6,64x
Capitalization 797 181 M
More Financials
Company
Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes Care and Biopharmaceuticals segments.The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas... 
Sector
Pharmaceuticals
Calendar
06/07 | 06:30pmPresentation
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVO NORDISK A/S
05/27 NOVO NORDISK A/S : Findings from Novo Nordisk Broaden Understanding of Ulcerativ..
05/27 NOVO NORDISK A/S : Patent Issued for Insulins with an Acyl Moiety Comprising Rep..
05/27 NOVO NORDISK A/S : Researchers from Novo Nordisk Report Findings in Proinsulin (..
05/27 EXCLUSIVE : Greece owes drugmakers $1.2 billion - and counting
05/22 NOVO NORDISK A/S : Treatment with Saxenda® for three years reduced the risk of d..
05/22 NOVO NORDISK A/S : Behandling med Saxenda® i tre år nedsætter risikoen for at ud..
05/22DJNOVO NORDISK A/S : Hails Success in Diabetes Drug Trial
05/21 NOVO NORDISK A/S : Share repurchase programme
More news
Sector news : Pharmaceuticals - NEC
05/29DJNew Cancer Immunotherapy Drugs Show Promise -- Update
05/29 ALEXION PHARMACEUTICALS : and Synageva Announce Early Termination of Hart-Scott-..
05/29 OPKO HEALTH : Announces Submission of Rayaldee™ New Drug Application to U...
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
05/28 EC clears Boehringer Ingelheim's Synjardy
05/27 Novo Nordisk And Its Promising Diabetes Drugs
05/27 Trial results show treatment with Novo's Saxenda delays onset of type 2 diabe..
05/26 Health Care Stocks For A Dividend Growth Portfolio - Part 2
05/26 Health Care Stocks For A Dividend Growth Portfolio - Part 1


Comments 
Advertisement
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions